Pasithea Therapeutics Corp. (KTTA)

0.8950 -0.0106 (-1.17%) At close: 04:00PM EDT

Pasithea Therapeutics Corp.

1111 Lincoln Road
Suite 500
Miami Beach, FL 33139
United States
702 514 4174
https://www.pasithea.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 3

Key Executives

Name	Title	Pay	Exercised	Year Born
Prof. Lawrence Steinman BA, M.D.	Exec. Chairman & Co-Founder	72.92k	N/A	1948
Dr. Tiago Reis Marques	CEO & Director	243.75k	N/A	1978
Mr. Stanley M. Gloss	Chief Financial Officer	67.5k	N/A	1960
Dr. Yassine Bendiabdallah Ph.D.	COO, Head of UK Clinics & Director	N/A	N/A	1986

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Corporate Governance

Pasithea Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.